Join Danielle Gatti Palumbo, a clinical pharmacist at the Division of Rheumatology at Northwell Health in Long Island, New York, as she discusses the dosing and monitoring of Guselkumab. Guselkumab is FDA-approved for the treatment of moderate to severely active psoriasis and active psoriatic arthritis in adults who are candidates for systemic therapy or phototherapy.
Information
- Show
- PublishedOctober 23, 2024 at 6:00 AM UTC
- Length2 min
- RatingClean